Dalton Bioanalytics

Dalton Bioanalytics is a private, early-stage CRO leveraging its proprietary Omni-MS® technology to offer integrated, one-shot multi-omics profiling services. The company aims to reduce the cost and complexity of traditional multi-omics studies by consolidating analysis of diverse analyte classes into a single assay, thereby improving data integrity for applications in drug development, biomarker discovery, and bioprocessing. While likely pre-revenue or early-revenue, Dalton has established key academic and industry partnerships and is positioned to capitalize on the growing demand for comprehensive biomarker data in precision medicine.

Omni-MS®: A proprietary LC-MS-based "one-shot" assay designed to profile proteins, lipids, metabolites, electrolytes, drugs, and environmental chemicals from a single sample preparation using advanced enzymatic and chemical techniques.

Dalton competes with large, full-service CROs (e.g., LabCorp, Q2 Solutions) that offer mass spectrometry, specialized proteomics/metabolomics firms (e.g., Olink, SomaLogic, Metabolon), and academic core facilities. Its differentiation is the integration of multiple analyte classes into a single, streamlined assay.